Skip to main content
Fig. 10 | Cancer Cell International

Fig. 10

From: Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro

Fig. 10

The potential mechanisms responsible for GPX3 downregulation in breast cancer. a The promoter methylation level of GPX3 was increased in breast cancer compared with normal controls. b The miRNA-GPX3 network. cf The prognostic values of four miRNAs in breast cancer. gj The expression levels of four miRNAs in breast cancer. k The intersection analysis of survival analysis and expression analysis. l The model of GPX3′s function and dysregulated mechanism in breast cancer. P < 0.05 was considered as statistically significant

Back to article page